Current opinion in ophthalmology · 2025
COVID-19: ocular manifestations and associations with corneal transplant rejection and uveitis reactivation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Saban Ori, Doan Thuy, Seitzman Gerami D
Аннотация
PURPOSE OF REVIEW: To highlight the ocular manifestations associated with COVID-19 and review the evidence surrounding proposed associations with corneal transplant rejection and uveitis reactivation.
RECENT FINDINGS: SARS-CoV-2 has been associated with various ocular manifestations, most commonly conjunctivitis. Less frequently, more severe complications such as uveitis, retinal vascular occlusions, and neuro-ophthalmic syndromes have been reported. These manifestations are theorized to occur secondary to both direct viral invasion as well as secondary systemic inflammation and immune dysregulation. While case reports suggest a possible link between COVID-19 infection and vaccination and corneal graft rejection, large cohort studies and meta-analyses have not confirmed an association. In contrast, retrospective data suggest a slight increase in uveitis recurrence following COVID-19 infection and vaccination in patients with prior uveitis.
SUMMARY: Ocular involvement in COVID-19 ranges from mild conjunctivitis to rare, vision-threatening inflammatory and vascular complications. While case reports have suggested temporal links between COVID-19 infection or vaccination and corneal transplant rejection or uveitis reactivation, current evidence does not support an association with graft rejection, and only a slight increase in uveitis recurrence has been observed in certain high-risk populations. With longer follow-up and prospective analyses, a clearer understanding of underlying mechanisms and risk factors may emerge to better guide ophthalmic management during and beyond the pandemic.
RECENT FINDINGS: SARS-CoV-2 has been associated with various ocular manifestations, most commonly conjunctivitis. Less frequently, more severe complications such as uveitis, retinal vascular occlusions, and neuro-ophthalmic syndromes have been reported. These manifestations are theorized to occur secondary to both direct viral invasion as well as secondary systemic inflammation and immune dysregulation. While case reports suggest a possible link between COVID-19 infection and vaccination and corneal graft rejection, large cohort studies and meta-analyses have not confirmed an association. In contrast, retrospective data suggest a slight increase in uveitis recurrence following COVID-19 infection and vaccination in patients with prior uveitis.
SUMMARY: Ocular involvement in COVID-19 ranges from mild conjunctivitis to rare, vision-threatening inflammatory and vascular complications. While case reports have suggested temporal links between COVID-19 infection or vaccination and corneal transplant rejection or uveitis reactivation, current evidence does not support an association with graft rejection, and only a slight increase in uveitis recurrence has been observed in certain high-risk populations. With longer follow-up and prospective analyses, a clearer understanding of underlying mechanisms and risk factors may emerge to better guide ophthalmic management during and beyond the pandemic.